Arjun Agarwal's most recent trade in Oruka Therapeutics Inc. was a trade of 8,541 shares done at an average price of $12.5 . Disclosure was reported to the exchange on Oct. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 12 Oct 2026 | 8,541 | 22,760 | - | 12.5 | 106,763 | - |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 80.03 per share. | 12 Oct 2026 | 5,741 | 18,477 | - | 80.0 | 459,453 | - |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 80.76 per share. | 12 Oct 2026 | 2,100 | 16,377 | - | 80.8 | 169,596 | - |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 81.85 per share. | 12 Oct 2026 | 1,958 | 14,419 | - | 81.9 | 160,272 | - |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.39 per share. | 12 Oct 2026 | 1,458 | 24,218 | - | 34.4 | 50,141 | - |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 82.84 per share. | 12 Oct 2026 | 200 | 14,219 | - | 82.8 | 16,567 | - |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 95.75 per share. | 21 Sep 2026 | 533 | 14,219 | - | 95.8 | 51,035 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 11 Sep 2026 | 8,000 | 23,312 | - | 12.5 | 100,000 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 11 Sep 2026 | 8,000 | 84,917 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 92.41 per share. | 11 Sep 2026 | 4,051 | 17,720 | - | 92.4 | 374,367 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 91.11 per share. | 11 Sep 2026 | 3,000 | 21,771 | - | 91.1 | 273,322 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 93.26 per share. | 11 Sep 2026 | 2,208 | 15,512 | - | 93.3 | 205,921 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.39 per share. | 11 Sep 2026 | 1,459 | 24,771 | - | 34.4 | 50,175 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 11 Sep 2026 | 1,459 | 58,333 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 95.71 per share. | 11 Sep 2026 | 560 | 14,752 | - | 95.7 | 53,598 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 94.02 per share. | 11 Sep 2026 | 200 | 15,312 | - | 94.0 | 18,803 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 13 Aug 2026 | 8,542 | 92,917 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 13 Aug 2026 | 8,542 | 23,854 | - | 12.5 | 106,775 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 108.46 per share. | 13 Aug 2026 | 2,358 | 15,312 | - | 108.5 | 255,755 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 107.71 per share. | 13 Aug 2026 | 2,142 | 17,670 | - | 107.7 | 230,723 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 105.57 per share. | 13 Aug 2026 | 2,132 | 21,080 | - | 105.6 | 225,079 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 104.67 per share. | 13 Aug 2026 | 2,100 | 23,212 | - | 104.7 | 219,814 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 13 Aug 2026 | 1,458 | 59,792 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.39 per share. | 13 Aug 2026 | 1,458 | 25,312 | - | 34.4 | 50,141 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 13 Aug 2026 | 1,268 | 19,812 | - | 106.6 | 135,201 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 13 Jul 2026 | 8,541 | 101,459 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 13 Jul 2026 | 8,541 | 23,853 | - | 12.5 | 106,763 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 84.90 per share. | 13 Jul 2026 | 5,656 | 15,612 | - | 84.9 | 480,201 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 84.26 per share. | 13 Jul 2026 | 3,743 | 21,268 | - | 84.3 | 315,369 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 13 Jul 2026 | 1,458 | 61,250 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.39 per share. | 13 Jul 2026 | 1,458 | 25,311 | - | 34.4 | 50,141 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 85.63 per share. | 13 Jul 2026 | 300 | 15,312 | - | 85.6 | 25,690 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 83.07 per share. | 13 Jul 2026 | 300 | 25,011 | - | 83.1 | 24,920 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 80.01 per share. | 22 Jun 2026 | 888 | 16,011 | - | 80.0 | 71,049 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 82.14 per share. | 22 Jun 2026 | 699 | 15,312 | - | 82.1 | 57,419 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 12 Jun 2026 | 8,000 | 110,000 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 12 Jun 2026 | 8,000 | 25,294 | - | 12.5 | 100,000 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 69.85 per share. | 12 Jun 2026 | 4,340 | 20,554 | - | 69.9 | 303,154 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 70.34 per share. | 12 Jun 2026 | 3,260 | 17,294 | - | 70.3 | 229,306 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 68.34 per share. | 12 Jun 2026 | 1,859 | 24,894 | - | 68.3 | 127,048 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.39 per share. | 12 Jun 2026 | 1,459 | 26,753 | - | 34.4 | 50,175 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 12 Jun 2026 | 1,459 | 62,708 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 69.69 per share. | 12 Jun 2026 | 395 | 16,899 | - | 69.7 | 27,528 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 18 May 2026 | 5,833 | 64,167 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.39 per share. | 18 May 2026 | 5,833 | 26,696 | - | 34.4 | 200,597 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 59.19 per share. | 18 May 2026 | 4,600 | 17,906 | - | 59.2 | 272,260 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 58.34 per share. | 18 May 2026 | 4,190 | 22,506 | - | 58.3 | 244,465 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 18 May 2026 | 2,000 | 20,863 | - | 12.5 | 25,000 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | 18 May 2026 | 2,000 | 118,000 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 60.34 per share. | 18 May 2026 | 800 | 17,106 | - | 60.3 | 48,269 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 61.16 per share. | 18 May 2026 | 700 | 16,406 | - | 61.2 | 42,812 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 41.30 per share. | 16 Mar 2026 | 395 | 18,863 | - | 41.3 | 16,314 | Common Stock |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | SVP, Finance | 23 Jan 2026 | 70,000 | 70,000 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | SVP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2026 | 17,500 | 19,258 | - | 0 | Common Stock | |
| Oruka Therapeutics Inc | Mr. Arjun Agarwal | SVP, Finance | 22 Jan 2025 | 120,000 | 120,000 | - | - | Employee Stock Option (right to buy) |